中文 | English
Return
Total: 4478 , 1/448
Show Home Prev Next End page: GO
Author:(Xin-xin ZHOU)

1.How to Protect the Vulnerable Groups in Drug Clinical Trials

Xin LIN ; Xin ZHOU

Chinese Medical Ethics 2017;30(5):572-575

2.Research on etiology and drug resistance analysis of ICU ventilator-associated pneumonia

Xin ZHOU

China Medical Equipment 2016;13(1):111-113

3.Study on in vitro models of drug absorption

Xin ZHOU

Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-

5.Expression and clinical significance of p73? in breast carcinoma tissues

Xin ZHOU

Journal of Chongqing Medical University 1986;0(04):-

6.Research progress of Bruton tyrosine kinase inhibitors in mantle cell lymphoma

Xiangxiang ZHOU ; Xin WANG

Journal of Leukemia & Lymphoma 2016;25(6):377-380

7.Clinical value of hippocampal gyrus protection in whole brain radiotherapy

Xin DONG ; Zongmei ZHOU

Chinese Journal of Radiation Oncology 2016;25(5):526-529

8.Analysis of the Use of Narcotic Analgetics in Our Hospital During 2005~2007

Jian SHEN ; Xin ZHOU

China Pharmacy 2005;0(20):-

9.Research progress on traditional Chinese medicine affecting the metabolism of cytochrome P450

Ruifang XIE ; Xin ZHOU

Chinese Journal of Clinical Pharmacology and Therapeutics 2002;0(06):-

10.Study progression of GLP-1 analogues in type 1 diabetes and islet transplant

Xin SU ; Zhiguang ZHOU

Chinese Journal of Endocrinology and Metabolism 2010;26(7):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 4478 , 1/448 Show Home Prev Next End page: GO